CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
Canopy Growth Corp
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72+0.00 (+0.38%)
Close on Oct 19, 2026
Share price
−$0.5943 (−45.37%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Canopy Growth Corp grew revenue 6.8% to C$293.63M over the twelve months to Jun 30, 2026. Free cash flow was -C$83.24M.
Revenue
C$293.63M
+6.8% vs. a year earlier
Operating income
-C$161.15M
TTM Q1 2027
Free cash flow
-C$83.24M
TTM Q1 2027
EPS, diluted
-0.62 CAD
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$293.63M
- Net income
- -C$232.63M
- EPS, diluted
- -0.62 CAD
- Free cash flow
- -C$83.24M
- Diluted shares
- 422M
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Eleven years at a glance
Fiscal years 2016 to 2026 and trailing twelve months, CAD
Revenue
C$293.63M+6.8% YoY
Gross profit
C$73.87M-0.9% YoY
Operating income
-C$161.15M
Net income
-C$232.63M
EPS, diluted
-0.62 CAD
Free cash flow
-C$83.24M
Reported periodTrailing twelve months